These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 10725265

  • 1. Vasorelaxant and antiplatelet activity of 4,7-dimethyl-1,2, 5-oxadiazolo[3,4-d]pyridazine 1,5,6-trioxide: role of soluble guanylate cyclase, nitric oxide and thiols.
    Kots AY, Grafov MA, Khropov YV, Betin VL, Belushkina NN, Busygina OG, Yazykova MY, Ovchinnikov IV, Kulikov AS, Makhova NN, Medvedeva NA, Bulargina TV, Severina IS.
    Br J Pharmacol; 2000 Mar; 129(6):1163-77. PubMed ID: 10725265
    [Abstract] [Full Text] [Related]

  • 2. The relaxant activity of 4,7-dimethyl-1,2,5-oxadiazolo[3,4-d]-pyridazine 1,5,6-trioxide in the mouse corpus cavernosum.
    Göçmen C, Büyüknacar HS, Kots AY, Murad F, Kiroglu O, Kumcu EK.
    J Pharmacol Exp Ther; 2006 Feb; 316(2):753-61. PubMed ID: 16254132
    [Abstract] [Full Text] [Related]

  • 3. Benzodifuroxan as an NO-dependent activator of soluble guanylate cyclase and a novel highly effective inhibitor of platelet aggregation.
    Bussygina OG, Pyatakova NV, Khropov YV, Ovchinnikov IV, Makhova NN, Severina IS.
    Biochemistry (Mosc); 2000 Apr; 65(4):457-62. PubMed ID: 10810184
    [Abstract] [Full Text] [Related]

  • 4. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
    Galle J, Zabel U, Hübner U, Hatzelmann A, Wagner B, Wanner C, Schmidt HH.
    Br J Pharmacol; 1999 May; 127(1):195-203. PubMed ID: 10369473
    [Abstract] [Full Text] [Related]

  • 5. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
    Mülsch A, Bauersachs J, Schäfer A, Stasch JP, Kast R, Busse R.
    Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
    [Abstract] [Full Text] [Related]

  • 6. A new class of furoxan derivatives as NO donors: mechanism of action and biological activity.
    Ferioli R, Folco GC, Ferretti C, Gasco AM, Medana C, Fruttero R, Civelli M, Gasco A.
    Br J Pharmacol; 1995 Feb; 114(4):816-20. PubMed ID: 7773542
    [Abstract] [Full Text] [Related]

  • 7. Echinacoside elicits endothelium-dependent relaxation in rat aortic rings via an NO-cGMP pathway.
    He WJ, Fang TH, Ma X, Zhang K, Ma ZZ, Tu PF.
    Planta Med; 2009 Oct; 75(13):1400-4. PubMed ID: 19468974
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.
    Homer KL, Wanstall JC.
    Br J Pharmacol; 2002 Dec; 137(7):1071-81. PubMed ID: 12429580
    [Abstract] [Full Text] [Related]

  • 9. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
    Olesen SP, Drejer J, Axelsson O, Moldt P, Bang L, Nielsen-Kudsk JE, Busse R, Mülsch A.
    Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
    [Abstract] [Full Text] [Related]

  • 10. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one (ODQ) inhibits relaxation of rabbit aortic rings induced by carbon monoxide, nitric oxide, and glyceryl trinitrate.
    Hussain AS, Marks GS, Brien JF, Nakatsu K.
    Can J Physiol Pharmacol; 1997 Aug; 75(8):1034-7. PubMed ID: 9360020
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
    Mellion BT, Ignarro LJ, Myers CB, Ohlstein EH, Ballot BA, Hyman AL, Kadowitz PJ.
    Mol Pharmacol; 1983 May; 23(3):653-64. PubMed ID: 6135148
    [Abstract] [Full Text] [Related]

  • 12. KMUP-1, a xanthine derivative, induces relaxation of guinea-pig isolated trachea: the role of the epithelium, cyclic nucleotides and K+ channels.
    Wu BN, Lin RJ, Lo YC, Shen KP, Wang CC, Lin YT, Chen IJ.
    Br J Pharmacol; 2004 Aug; 142(7):1105-14. PubMed ID: 15237094
    [Abstract] [Full Text] [Related]

  • 13. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
    Gordge MP, Hothersall JS, Noronha-Dutra AA.
    Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
    Severina IS, Belushkina NN, Grigoryev NB.
    Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
    [Abstract] [Full Text] [Related]

  • 15. Ursolic acid mediates the vasorelaxant activity of Lepechinia caulescens via NO release in isolated rat thoracic aorta.
    Aguirre-Crespo F, Vergara-Galicia J, Villalobos-Molina R, Javier López-Guerrero J, Navarrete-Vázquez G, Estrada-Soto S.
    Life Sci; 2006 Aug 08; 79(11):1062-8. PubMed ID: 16630635
    [Abstract] [Full Text] [Related]

  • 16. Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-induced relaxation in guinea-pig trachea.
    Hwang TL, Wu CC, Teng CM.
    Br J Pharmacol; 1998 Nov 08; 125(6):1158-63. PubMed ID: 9863642
    [Abstract] [Full Text] [Related]

  • 17. Mechanism of ITF 296-induced vasorelaxation compared to nitroglycerin and isosorbide dinitrate: relationship between relaxation of rabbit aorta and tissue cGMP.
    Donà G, Giuliani P, Cremonesi P, Passaro A, Stella P, Tursi F, Mizrahi J.
    J Cardiovasc Pharmacol; 1995 Nov 08; 26 Suppl 4():S59-66. PubMed ID: 8839228
    [Abstract] [Full Text] [Related]

  • 18. Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat.
    Wegener JW, Gath I, Förstermann U, Nawrath H.
    Br J Pharmacol; 1997 Dec 08; 122(7):1523-9. PubMed ID: 9421305
    [Abstract] [Full Text] [Related]

  • 19. The involvement of the release of nitric oxide in the pharmacological activity of the new furoxan derivative CHF 2363.
    Civelli M, Giossi M, Caruso P, Razzetti R, Bergamaschi M, Bongrani S, Gasco A.
    Br J Pharmacol; 1996 Jun 08; 118(4):923-8. PubMed ID: 8799563
    [Abstract] [Full Text] [Related]

  • 20. BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine]-induced dilation in ovine pulmonary artery: role of sodium pump.
    Bawankule DU, Sathishkumar K, Sardar KK, Chanda D, Krishna AV, Prakash VR, Mishra SK.
    J Pharmacol Exp Ther; 2005 Jul 08; 314(1):207-13. PubMed ID: 15792996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.